Lee M Kaplan

16PUBLICATIONS
97CO-AUTHORS
PharmacogenomicsSolid tumoursInnate immunityPharmaceutical delivery technologiesExercise physiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jun 07, 2026
Survodutide in adults with obesity and metabolic dysfunction-associated steatotic liver disease: SYNCHRONIZE-MASLD, a randomized, double-blind, placebo-controlled phase 3 trial.

|Mar 03, 2026
Weight-related changes in MRI-derived measures of body composition and liver steatosis: a large-scale analysis for obesity trial design.

Magdalena Nowak, Luis Núñez, Tim Pagliaro

|Dec 24, 2025
Inspiratory Muscle Performance and Its Correlates Among Division I American Football Players.

Luis A Feigenbaum, Lawrence P Cahalin, Jeffrey T Ruiz

|Nov 11, 2025
Baseline characteristics in the SYNCHRONIZE™-2 randomized phase 3 trial of survodutide, a glucagon receptor/GLP-1 receptor dual agonist, for obesity in people with type 2 diabetes.

Sean Wharton, Carel W le Roux, Biykem Bozkurt

|Nov 04, 2025
Survodutide for treatment of obesity: Baseline characteristics of participants in a randomized, double-blind, placebo-controlled, phase 3 trial (SYNCHRONIZE™-1).

Carel W le Roux, Sean Wharton, Biykem Bozkurt

|Nov 04, 2025
People With Lowest Physical Functioning Scores Showed Greatest Improvement After Tirzepatide Treatment.

Xuan Li, Dachuang Cao, Helene Sapin

Pageof 3

Frequent Collaborators

6 joint publications

Carel W le Roux

4 joint publications

Biykem Bozkurt

4 joint publications

Samina Ajaz Hussain

3 joint publications

Sean Wharton